France’s biggest drug maker Sanofi SA (ADR) (NYSE:SNY) aims to begin building a $75M plant in Vietnam as increasing income and urbanization increased demand for health care in Asia.
According to an e-mailed statement, the firm, which has been in the country of almost 90M for over 50 years, will create at an initial capacity of 90M units a year at the new facility at what time it starts operations by the end of 2015 and might later expand to 150M units. It at present runs two plants in Ho Chi Minh City at full capacity, according to Sanofi CEO Chris Viehbacher.
Viehbacher reported in an interview yesterday in Hanoi that Asia continues to produce and it appears to be less affected by the European economic complexity in contrast with other regions in the world, as there’s a lot of trading leaving on amid Asian countries.
Coming to the stock performance in last Session; Sanofi SA (ADR) (NYSE:SNY) in last trading session end up at $51.08 by rising up 1.85% with traded volume of 3.02 million shares which is up the average volume of 2.62 million shares.
The stock price saw week’s volatility of 1.54% and month’s volatility is 1.40%, while the stock price of the company is moving up from its 20 days moving average with 3.85% and isolated positively from 50 days moving average with 5.29%.
Looking at Analytic Ratios; the price to sales ratio of SNY in past twelve months was calculated as 2.91 and price to cash ratio as 16.40. Company return on equity ratio is recorded as 8.75% and its return on assets is 4.72%.
SNY belongs to Healthcare sector. Yesterday Dow Jones U.S. Healthcare Index (SHC) was at 484.92 with 0.97% change.